198 related articles for article (PubMed ID: 28899969)
1. TMEM16A/ANO1 Inhibits Apoptosis Via Downregulation of Bim Expression.
Godse NR; Khan N; Yochum ZA; Gomez-Casal R; Kemp C; Shiwarski DJ; Seethala RS; Kulich S; Seshadri M; Burns TF; Duvvuri U
Clin Cancer Res; 2017 Dec; 23(23):7324-7332. PubMed ID: 28899969
[No Abstract] [Full Text] [Related]
2. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
[TBL] [Abstract][Full Text] [Related]
3. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
Stauber RH; Knauer SK; Habtemichael N; Bier C; Unruhe B; Weisheit S; Spange S; Nonnenmacher F; Fetz V; Ginter T; Reichardt S; Liebmann C; Schneider G; Krämer OH
Oncotarget; 2012 Jan; 3(1):31-43. PubMed ID: 22289787
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca
Wang H; Wang T; Zhang Z; Fan Y; Zhang L; Gao K; Luo S; Xiao Q; Sun C
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1699-1711. PubMed ID: 33755783
[TBL] [Abstract][Full Text] [Related]
5. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
Kulkarni S; Bill A; Godse NR; Khan NI; Kass JI; Steehler K; Kemp C; Davis K; Bertrand CA; Vyas AR; Holt DE; Grandis JR; Gaither LA; Duvvuri U
Genes Chromosomes Cancer; 2017 Jun; 56(6):460-471. PubMed ID: 28177558
[TBL] [Abstract][Full Text] [Related]
6. To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN.
Shiwarski DJ; Shao C; Bill A; Kim J; Xiao D; Bertrand CA; Seethala RS; Sano D; Myers JN; Ha P; Grandis J; Gaither LA; Puthenveedu MA; Duvvuri U
Clin Cancer Res; 2014 Sep; 20(17):4673-88. PubMed ID: 24919570
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Ca
Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
[TBL] [Abstract][Full Text] [Related]
9. Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.
Vyas A; Duvvuri U; Kiselyov K
Biochem J; 2019 Dec; 476(24):3705-3719. PubMed ID: 31790150
[TBL] [Abstract][Full Text] [Related]
10. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.
Vyas A; Gomez-Casal R; Cruz-Rangel S; Villanueva H; Sikora AG; Rajagopalan P; Basu D; Pacheco J; Hammond GRV; Kiselyov K; Duvvuri U
Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2100670119. PubMed ID: 35286200
[TBL] [Abstract][Full Text] [Related]
12. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
13. p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
Yassin-Kassab A; Chatterjee S; Khan N; Wang N; Sandulache VC; Huang EH; Burns TF; Duvvuri U
BMC Cancer; 2024 Feb; 24(1):233. PubMed ID: 38373988
[TBL] [Abstract][Full Text] [Related]
14. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
[TBL] [Abstract][Full Text] [Related]
16. Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers.
Li F; Shanmugam MK; Siveen KS; Wang F; Ong TH; Loo SY; Swamy MM; Mandal S; Kumar AP; Goh BC; Kundu T; Ahn KS; Wang LZ; Hui KM; Sethi G
Oncotarget; 2015 Mar; 6(7):5147-63. PubMed ID: 25762616
[TBL] [Abstract][Full Text] [Related]
17. Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells.
Yoshimoto S; Matsuda M; Kato K; Jimi E; Takeuchi H; Nakano S; Kajioka S; Matsuzaki E; Hirofuji T; Inoue R; Hirata M; Morita H
Eur J Pharmacol; 2021 Mar; 895():173881. PubMed ID: 33476655
[TBL] [Abstract][Full Text] [Related]
18. Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer.
Bauer JA; Kumar B; Cordell KG; Prince ME; Tran HH; Wolf GT; Chepeha DB; Teknos TN; Wang S; Eisbruch A; Tsien CI; Urba SG; Worden FP; Lee J; Griffith KA; Taylor JM; D'Silva N; Wang SJ; Wolter KG; Henson B; Fisher SG; Carey TE; Bradford CR
Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S106-8. PubMed ID: 17848273
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
[TBL] [Abstract][Full Text] [Related]
20. Cell-specific mechanisms of TMEM16A Ca
Wang H; Zou L; Ma K; Yu J; Wu H; Wei M; Xiao Q
Mol Cancer; 2017 Sep; 16(1):152. PubMed ID: 28893247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
